background
respiratori
viral
diagnosi
upper
respiratori
tract
infect
larg
develop
multiplex
molecular
techniqu
although
sensit
differ
type
upper
respiratori
tract
sampl
seem
correl
number
sampl
cell
link
remain
larg
unexplor
method
studi
includ
upper
respiratori
tract
specimen
neg
posit
viral
detect
multiplex
pcr
sampl
select
match
age
group
posit
group
sampl
select
detect
viral
speci
result
among
factor
influenc
cellular
type
sampl
p
patient
age
p
viral
posit
neg
natur
sampl
p
posit
sampl
number
viral
target
detect
p
viral
speci
conclus
cellular
load
upper
respiratori
sampl
multifactori
occur
mani
sensit
molecular
detect
howev
possibl
determin
minimum
cellular
threshold
allow
molecular
viral
detect
differ
accord
type
viru
remain
studi
larger
scale
associ
particular
diseas
respiratori
syncyti
viru
bronchiol
parainfluenza
viru
laryng
rhinoviru
common
cold
influenza
viru
flu
syndrom
evid
clinic
specif
virolog
diagnosi
provid
accur
identif
ari
detect
respiratori
virus
littl
interest
gener
practic
infect
present
risk
sever
patient
howev
virolog
confirm
ari
need
sever
clinic
present
requir
hospit
intens
care
unit
occur
vulner
subject
goal
earli
virolog
diagnosi
would
optim
patient
care
could
lead
reduct
length
hospit
stay
save
antibiot
complementari
examin
virolog
test
allow
establish
accur
diagnosi
infect
assess
evolv
risk
bacteri
infect
acut
respiratori
distress
syndrom
establish
measur
limit
spread
isol
wear
glove
mask
pandem
sever
acut
respiratori
syndrom
sar
sar
influenza
lead
develop
molecular
biolog
techniqu
appli
virolog
diagnosi
mainli
base
pcr
polymeras
chain
reaction
perform
molecular
method
respiratori
virolog
signific
replac
convent
techniqu
cultur
detect
viral
antigen
refer
method
multiplex
pcr
techniqu
particularli
suit
medic
diagnosi
detect
multipl
viral
target
time
avoid
virologist
select
viral
target
search
mani
commerci
kit
detect
rang
respiratori
virus
intracellular
bacteria
molecular
techniqu
realtim
pcr
also
make
possibl
achiev
semi
quantif
viral
molecular
materi
present
sampl
give
addit
inform
respiratori
viral
load
interest
therapeut
monitor
infect
transmiss
risk
normal
viral
load
obtain
ad
cell
quantif
step
primari
site
replic
respiratori
virus
ciliat
airway
epithelium
sampl
must
taken
soon
possibl
onset
symptom
usual
nasal
swab
nasopharyng
aspir
especi
realiz
children
sampl
easili
access
especi
adapt
upper
ari
rich
cell
collect
appear
import
prerequisit
qualiti
respiratori
viral
diagnosi
current
inform
possibl
cellular
threshold
would
valid
result
viral
molecular
detect
main
object
work
studi
cellular
respiratori
specimen
previous
character
virolog
result
help
defin
concept
cellular
rich
determin
factor
influenc
eight
hundr
respiratori
sampl
includ
studi
collect
septemb
februari
differ
depart
univers
hospit
caen
franc
immedi
sent
virolog
depart
respiratori
viral
diagnosi
respiratori
sampl
divid
nasal
swab
correspond
nasopharynx
sampl
posterior
nare
collect
univers
viral
transport
medium
utm
nasal
aspir
receipt
laboratori
sampl
underw
preanalyt
step
includ
divis
aliquot
one
immedi
use
viral
detect
two
store
frozen
one
two
frozen
fraction
use
studi
complementari
diagnost
studi
conduct
residu
clinic
specimen
french
law
right
use
end
sampl
written
code
public
health
code
de
la
publiqu
articl
aliquot
select
laboratori
sampl
bank
accord
result
virolog
diagnosi
posit
neg
molecular
detect
respiratori
panel
use
respifind
techniqu
pathofind
maastricht
netherland
kit
allow
detect
rna
dna
viral
target
intracellular
bacteri
target
respiratori
specimen
tabl
total
age
group
reflect
distribut
observ
practic
laboratori
indic
follow
infant
age
n
children
age
n
adult
age
n
elderli
age
n
group
compos
half
posit
half
neg
molecular
viral
detect
match
age
within
group
posit
sampl
distribut
detect
viral
speci
model
observ
routin
activ
laboratori
tabl
thaw
sampl
extract
nucleic
acid
perform
use
plc
qiagen
hilden
germani
extract
perform
sampl
use
qiasymphonydspviru
cell
quantif
achiev
amplif
detect
human
household
gene
realtim
pcr
hypoxanthin
phosphoribosyl
cell
quantif
perform
lightcycl
platform
roch
meylan
franc
reaction
mixtur
includ
amplif
premix
cellcontrol
argenebiomerieux
lyon
franc
nucleic
acid
extract
manipul
includ
two
neg
control
one
undergo
analyt
step
call
ec
extract
control
one
introduc
prior
pcr
reaction
call
neg
control
cell
quantif
standard
cellspcr
cellspcr
readi
use
kit
extern
standard
curv
perform
use
two
standard
addit
dilut
respect
contain
cellspcr
read
result
carri
directli
plc
softwar
display
ct
valu
cycl
threshold
obtain
correspond
number
cellspcrreact
ie
extract
number
convert
cellsml
final
result
express
logarithm
scale
quantif
kit
perform
verifi
laboratori
quantifi
cell
human
embryon
fibroblast
known
concentr
rdbiothech
besancon
franc
rang
serial
dilut
made
initi
cell
suspens
viral
transport
medium
utm
nucleic
acid
extract
cell
suspens
cell
quantif
reaction
carri
condit
respiratori
sampl
descript
statist
use
show
characterist
differ
variabl
quantit
variabl
describ
use
mean
standard
deviat
qualit
variabl
describ
use
frequenc
percentag
relationship
qualit
variabl
studi
use
chisquar
test
fisher
exact
test
anova
use
compar
mean
quantit
variabl
two
independ
group
bonferroni
post
hoc
test
relationship
two
quantit
variabl
assess
use
spearman
correl
coeffici
look
diagnost
threshold
divid
posit
neg
sampl
receiv
oper
characterist
curv
roc
curv
use
test
twotail
level
signific
p
defin
p
statist
softwar
use
serial
dilut
rang
initi
suspens
expect
cellular
valu
log
ml
concentr
given
manufactur
logml
last
dilut
measur
cellular
valu
consist
expect
concentr
log
last
dilut
deviat
log
expect
valu
correspond
concentr
log
tabl
mean
deviat
expect
valu
logml
regard
sampl
popul
cell
quantif
neg
dna
detect
posit
neg
viral
detect
compar
studi
sampl
swab
nasal
aspir
among
cellquantifi
respiratori
sampl
nasal
aspir
nasal
swab
cellular
result
present
tabl
regard
nasal
swab
averag
cellular
significantli
differ
age
group
except
children
compar
adult
p
comparison
cellular
among
posit
n
neg
n
sampl
viral
detect
subject
match
age
age
distribut
ident
two
group
posit
neg
p
two
group
compar
expect
averag
cellular
logml
posit
group
log
ml
neg
group
differ
signific
p
result
comparison
age
group
accord
result
viral
detect
posit
neg
present
fig
within
singl
age
group
infant
children
adult
elderli
differ
posit
neg
sampl
signific
p
p
p
p
respect
base
result
comparison
posit
neg
sampl
roc
receiv
oper
characterist
curv
perform
minimum
cellular
threshold
could
defin
molecular
viral
detect
fig
aspir
swab
fig
averag
cellular
respiratori
specimen
depend
sampl
type
age
group
nasal
aspir
sampl
type
provid
averag
epitheli
cell
patient
age
logml
aspir
versu
logml
swab
b
although
shape
averag
cellular
curv
posit
sampl
alway
locat
neg
among
select
sampl
viral
detect
neg
posit
viral
target
posit
target
posit
target
averag
cellular
logml
logml
logml
logml
group
respect
averag
cellular
neg
sampl
significantli
lower
case
mono
p
bi
p
tridetect
p
signific
tendenc
observ
posit
sampl
one
viral
target
posit
viru
p
trend
confirm
spearman
correl
indic
strong
correl
sampl
cellular
number
virus
detect
molecular
detect
includ
multiplex
techniqu
current
gold
standard
viral
respiratori
diagnosi
power
molecular
tool
ensur
qualiti
respiratori
viral
diagnosi
avail
clinician
support
hospit
patient
one
factor
limit
diagnosi
repres
collect
respiratori
specimen
main
object
work
studi
cellular
clinic
respiratori
specimen
propos
possibl
definit
commonli
call
cellular
rich
measur
impact
marker
molecular
viral
diagnosi
publish
studi
complet
area
howev
number
fact
commonli
accept
within
medic
commun
respiratori
specimen
rich
allow
good
viral
diagnosi
good
sampl
obtain
almost
exclus
infant
children
total
identifi
studi
publish
intern
journal
whose
object
compar
variou
upper
respiratori
sampl
term
sampl
equip
flock
swab
versu
rayon
swab
term
sampl
site
nasal
oropharyng
nasopharyng
combin
site
sampl
modal
swab
wash
aspir
number
target
cell
andor
number
extracellular
viral
particl
collect
could
defin
respiratori
sampl
qualiti
sampl
unreason
consid
major
viral
sequenc
detect
molecular
techniqu
mainli
locat
intracellular
compart
howev
sever
factor
could
modul
distribut
viral
speci
cytopath
effect
induc
vivo
inflammatori
respons
sampl
delay
onset
symptom
studi
retrospect
therefor
possibl
collect
data
time
sampl
clinic
symptom
standard
way
matter
nonetheless
interest
remain
explor
studi
consid
cell
quantif
cellular
rich
main
marker
diagnost
efficaci
sampl
studi
referenc
use
indirect
measur
sampl
rich
viru
detect
use
molecular
detect
method
one
antigen
detect
use
rapid
diagnost
test
evalu
number
infect
uninfect
cell
deposit
slide
overal
result
consist
show
superior
nasopharyng
swab
versu
oropharyng
superior
flock
swab
versu
classic
one
superior
wash
versu
swab
found
author
come
well
counteract
widespread
idea
wash
alway
greater
swab
alsaleh
et
al
perform
molecular
cell
quantif
use
real
time
pcr
order
valid
viral
detect
nasal
swab
cellular
sampl
assess
use
quantif
human
endogen
retroviru
known
present
two
copi
per
diploid
cell
author
report
result
compar
ct
obtain
upon
detect
term
cellular
load
studi
made
choic
use
direct
detect
method
assess
number
cell
respiratori
sampl
extent
need
larg
number
sampl
character
mani
marker
statist
analysi
age
sampl
patient
detect
viral
target
etc
prospect
studi
freshli
sampl
respiratori
specimen
could
perform
therefor
use
previous
character
store
frozen
respiratori
sampl
definit
cellular
rich
affect
freez
thaw
sampl
sinc
theoret
chang
amount
nucleic
acid
ie
copi
per
haploid
cell
whether
lyse
similarli
distinct
live
dead
cell
made
freez
process
distinct
affect
qualiti
molecular
detect
pcr
detect
viral
genom
infect
cell
live
analysi
sampl
divid
posit
neg
viral
detect
fail
establish
minimum
cellular
threshold
invalid
neg
result
viral
molecular
detect
roc
curv
show
cellular
quantifi
predictor
outcom
viru
detect
howev
work
yield
interest
result
concern
factor
influenc
cellular
sampl
impact
cellular
result
molecular
detect
respiratori
virus
clearli
demonstr
nasal
aspir
allow
us
collect
cell
nasal
swab
age
group
year
old
result
must
temper
fact
nasal
aspir
studi
children
year
age
sinc
distribut
random
inclus
sampl
studi
reflect
common
practic
sampl
method
clinic
depart
nasal
aspir
rare
perform
adult
elderli
year
old
gestur
consid
invas
unpleas
result
support
idea
de
facto
would
appropri
perform
type
sampl
group
type
sampl
swab
andor
nasal
aspir
age
sampl
patient
remain
import
marker
influenc
cellular
maximum
averag
cellular
age
minimum
averag
cellular
adult
group
intermedi
averag
cellular
elderli
group
reason
lack
cellular
respiratori
sampl
adult
remain
obscur
regard
influenc
cellular
result
viral
detect
note
neg
sampl
present
age
group
combin
averag
cellular
lower
obtain
posit
sampl
even
though
possibl
establish
predict
relationship
differ
tenuou
children
group
observ
lead
two
possibl
explan
either
posit
group
infect
increas
sampl
cellular
promot
epitheli
desquam
lesser
extent
mucu
captur
contain
free
viral
particl
neg
group
falseneg
viru
detect
induc
lack
cell
sampl
result
obtain
sampl
aspir
swab
insofar
aspir
evenli
distribut
posit
neg
group
think
result
comparison
bias
given
aspir
richer
sampl
consid
viral
detect
entireti
without
analysi
viral
speci
detect
interest
note
two
factor
cellular
viral
codetect
detect
virus
associ
posit
suggest
detect
sever
virus
facilit
context
rich
sampl
case
viral
codetect
question
whether
cell
infect
resolv
even
convent
accept
alreadi
infect
cell
less
permiss
second
viral
infect
also
note
viral
codetect
either
coinfect
two
sequenti
infect
phenomena
alreadi
discuss
work
alsaleh
et
al
show
posit
sampl
viral
detect
averag
greater
amount
genet
materi
human
origin
neg
one
similarli
sampl
gene
detect
lower
viral
detect
final
also
found
posit
sampl
sever
virus
also
cellular
load
highest
analysi
potenti
impact
cellular
specif
detect
variou
virus
includ
respiratori
panel
show
result
confirm
larger
number
group
inde
one
hand
highest
averag
cellular
obtain
hmpv
posit
sampl
equal
detect
among
adult
children
group
hand
lowest
averag
cellular
obtain
rsv
posit
sampl
mostli
detect
infant
children
group
result
surpris
two
virus
rsv
hmpv
belong
viru
famili
paramyxovirida
well
viru
subfamili
pneumovirina
genet
close
mani
similar
circulatori
mode
pathophysiolog
infect
caus
yet
cellular
hmpv
posit
sampl
significantli
greater
rsv
posit
specimen
qualiti
sampl
dramat
affect
qualiti
result
provid
clinician
import
better
understand
sampl
characterist
goe
along
technolog
develop
work
uncommon
tri
give
answer
trivial
scientif
question
respiratori
specimen
rich
cell
ensur
optim
virolog
molecular
diagnosi
cellular
load
multifactori
occur
mani
sensit
molecular
detect
howev
possibl
determin
minimum
threshold
allow
molecular
viral
detect
adv
adenoviru
ari
acut
respiratori
infect
ct
cycl
threshold
dna
deoxyribonucl
acid
ec
extract
control
human
endogen
retroviru
flu
influenza
viru
hbov
human
bocaviru
hcov
human
coronaviru
hmpv
human
metapneumoviru
pcr
polymeras
chain
reaction
piv
parainfluenza
viru
rhvev
rhinoentero
viru
rna
ribonucl
acid
roc
receiv
oper
characterist
rsv
human
respiratori
syncyti
viru
sar
sever
acut
respiratori
syndrom
utm
univers
transport
medium
